Monday, March 27, 2006

FDA Statement on Tysabri Review Time

FDA Statement on Tysabri Review Time
Kansas City infoZine - Kansas City,MO,USA
... on March 22, 2006, that the Food and Drug Administration (FDA) had extended the regulatory review period for the reintroduction of Tysabri (natalizumab) for ...
See all stories on this topic

0 Comments:

Post a Comment

<< Home